
Beaufort Capital exits getemed
Beaufort Capital has sold its 32% stake in medical technology company getemed to the firm’s management.
The transaction was financed via a senior loan from Deutsche Bank, a silent partnership with the Mittelständische Beteiligungsgesellschaft Berlin-Brandenburg and the buyers' own equity.
Michael Scherf and Robert Downes now jointly hold slightly more than 50%, while getemed founder Herwig Freiherr von Nettelhorst holds an estimated 30% stake in the firm.
Beaufort originally invested in getemed in 2007, when acquiring the shares in the firm from Berlin Capital Fund in a secondary buyout.
Company
getemed was founded in 1984 and is headquartered in Teltow, near Berlin. The firm researches, develops and manufacturers technology for medical monitors and cardiological functional diagnostics.
People
Stefan Friese is partner at Beaufort.
Advisers
Equity – Network Corporate Finance (Corporate finance).
Vendor – Warth & Klein Grant Thornton (M&A).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater